TCRT - Alaunos Therapeutics, Inc.
Previous close
1.74
0.040 2.299%
Share volume: 21,765
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$1.70
0.04
0.02%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-15 | 2024-08-14 | 2024-11-14 | |
| Cash flow financing | 0.000 | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -1.917 M | 0.000 | 0.000 | |
| Net income | -1.682 M | -1.129 M | -1.127 M | |
| Depreciation | 2.000 K | 1.000 K | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | -1.917 M | -1.681 M | -781.000 K |